F.D.A. Expedites Review of New Uses for Xarelto, an Anticlotting Drug
Tuesday, July 10, 2012 - 00:20
in Health & Medicine
Johnson & Johnson, a developer of the drug, has asked the agency to approve Xarelto to treat deep vein thrombosis and pulmonary embolism.